Answer:
1 heat and no resources for new organisms  2 frogs may bred to be a different color there are disadvantages and advantages to natural selection the bird eats the lighter color frog and the darker frog lives
make sense?
Explanation:
 
        
             
        
        
        
Answer:
Plant cells form a cell plate between the two daughter cells. In animal cells, a cleavage furrow is formed between the two daughter cells.
Explanation:
 
        
             
        
        
        
Answer:
Amok.
Explanation:
Amok may be defined as a type of the culture bound syndrome and may occur due to the feeling of jealousy by an individual. Amok can be brought by the humiliation and desperation feeling.
The main characteristics of amok is aggression, brooding period outburst by violent and homicidal behavior towards people and object. The individual can do murder as well.
Thus, the answer is amok. 
 
        
             
        
        
        
A suspension is a heterogeneous mixture in which solute-like particles settle out of a solvent-like phase sometime after their introduction.
        
             
        
        
        
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III)  of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings 
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).  
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks  of the last dose of investigational drug).
Hence, the clinical phase is phase III.